Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy
- PMID: 23775296
- PMCID: PMC4500055
- DOI: 10.1002/lary.24254
Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy
Abstract
Objectives/hypothesis: To review the known histopathologic findings and clinical behavior of mammary analogue secretory carcinoma (MASC).
Data sources: PubMed.
Review methods: Literature search using the terms "Mammary analogue secretory carcinoma," "Mammary analog secretory carcinoma," and "MASC" to identify all relevant publications.
Results: MASC is an unusual and rare malignant salivary gland tumor first described in 2010. It shares histologic, immunohistochemical, and genetic features with secretory carcinoma of the breast. The clinical behavior of MASC ranges from slowly growing tumors that infrequently recur after surgical resection to aggressive tumors that cause widespread metastasis and death. Many cases of MASC were discovered in archived cases previously classified as acinic cell carcinoma, mucoepidermoid carcinoma, and adenocarcinoma not otherwise specified.
Conclusion: MASC is a newly recognized variant of salivary gland malignancy. Further research is needed to better delineate its overall prevalence and to define an appropriate treatment algorithm for this new clinical entity.
Keywords: Salivary gland carcinoma; head and neck surgery; mammary analogue secretory carcinoma; parotid malignancy.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.
Figures
References
-
- Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608. - PubMed
-
- Ozguroglu M, Tascilar K, Ilvan S, Soybir G, Celik V. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68:263–268. - PubMed
-
- Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–376. - PubMed
-
- Wai DH, Knezevich SR, Lucas T, Jansen B, Kay RJ, Sorensen PH. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene. 2000;19:906–915. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
